On August 19, 2020, Cellivery Therapeutics, Inc. (KOSDAQ:A268600) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,680 KRW | -29.91% | -.--% | -.--% |
2023 | Cellivery Therapeutics, Inc.(KOSDAQ:A268600) dropped from S&P Global BMI Index | CI |
2021 | Cellivery Therapeutics, Inc. acquired Ajin Clean Co., Ltd. from SVAJ Holdings for KRW 14.2 billion. | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
130,600 KRW | -2.17% | -1.06% | 2.6B | ||
5,130 KRW | -1.35% | +2.91% | 191M | ||
1st Jan change | Capi. | |
---|---|---|
-.--% | 182M | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- A268600 Stock
- News Cellivery Therapeutics, Inc.
- Cellivery Therapeutics, Inc. announced that it has received KRW 43.9988081 billion in funding from a group of investors